Reuters -- Denmark-based Novo Nordisk, a leading maker of diabetes care products, said on Monday it has agreed to pay $18 million to settle U.S. investigations into the company’s sales to Iraq as part of the United Nations’ oil for food program.
Reuters -- Denmark-based Novo Nordisk, a leading maker of diabetes care products, said on Monday it has agreed to pay $18 million to settle U.S. investigations into the company’s sales to Iraq as part of the United Nations’ oil for food program.
